Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Piracetam is a drug that has efficacy in cognitive disorders, vertigo, cortical myoclonus, dyslexia, and sickle cell anemia; sources differ on its usefulness for dementia. Piracetam is sold as a medication in many European countries. Piracetam in the United States is not approved for general use.
History, Community, Culture & Regions
Explore the main themes, entities and connections around Piracetam. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
drug brain dementia prescription use depression effects levetiracetam action evidence may cognitive united efficacy food drugs anxiety adhd found cell
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Piracetam | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Piracetam | AHFS/Drugs.com | International Drug Names | 1.00 | infobox |
| Piracetam | ATC code | N06BX03 (WHO) | 1.00 | infobox |
| Piracetam | Bioavailability | ~100% | 1.00 | infobox |
| Piracetam | CAS Number | 7491-74-9 Y | 1.00 | infobox |
| Piracetam | ChEMBL | ChEMBL36715 Y | 1.00 | infobox |
| Piracetam | ChemSpider | 4677 Y | 1.00 | infobox |
| Piracetam | CompTox Dashboard (EPA) | DTXSID5044491 | 1.00 | infobox |
| Piracetam | DrugBank | DB09210 | 1.00 | infobox |
| Piracetam | ECHA InfoCard | 100.028.466 | 1.00 | infobox |
| Piracetam | Elimination half-life | 4–5 hours | 1.00 | infobox |
| Piracetam | Excretion | Urinary | 1.00 | infobox |
| Piracetam | Formula | C6H10N2O2 | 1.00 | infobox |
| Piracetam | IUPHAR/BPS | 4288 | 1.00 | infobox |
| Piracetam | KEGG | D01914 Y | 1.00 | infobox |
| Piracetam | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Piracetam | Legal status | CA: Unscheduled | 1.00 | infobox |
| Piracetam | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Piracetam | Legal status | US: Unapproved drug, use in dietary supplements, food, or medicine is unlawful; otherwise uncontrolled | 1.00 | infobox |
| Piracetam | Melting point | 152 °C (306 °F) | 1.00 | infobox |
| Piracetam | Molar mass | 142.158 g·mol−1 | 1.00 | infobox |
| Piracetam | Onset of action | Swiftly following administration. Food delays time to peak concentration by 1.5 h approximately to 2–3 h since dosing. | 1.00 | infobox |
| Piracetam | PubChem CID | 4843 | 1.00 | infobox |
| Piracetam | Routes of administration | By mouth, parenteral, inhalation | 1.00 | infobox |
| Piracetam | Trade names | Breinox, Dinagen, Lucetam, Nootropil, Nootropyl, Oikamid, Piracetam, others | 1.00 | infobox |
| Piracetam | UNII | ZH516LNZ10 | 1.00 | infobox |
| Piracetam | is a | drug that has efficacy in cognitive disorders | 0.90 | text |
| Piracetam | is a | positive allosteric modulator of the AMPA receptor | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.